Skip to main navigation
Theratechnologies Inc. Theratechnologies Inc.

    About

  • About
    • About Us
    • Board of Directors
    • Leadership Team
    • Scientific Consultants & Advisors
    • Awards
  • Medicines & Pipeline

  • Medicines & Pipeline
    • Medicines
      • Trogarzo®
      • EGRIFTA SV®
    • Pipeline & Science
      • HIV
        • F8 in HIV-Associated Excess Abdominal Fat
        • Scientific Papers
        • Clinical Trials
        • Patient Information
      • Hepatology
        • Tesamorelin for the Potential Treatment of NASH
        • Scientific Papers
        • Clinical Trials
        • Patient Information
      • Oncology
        • SORT1+ Technology™
        • TH1902
        • Scientific Papers
        • Clinical Trials
        • Patient Information
      • Expanded Access Policy
      • Grants/ISRs/IITs
  • IR Nav

  • Investors
    • Overview
    • News, Events & Presentations
      • Press Releases
      • Company Announcements
      • Events
      • Corporate Presentations
    • Stock Information
      • Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financial Information
      • SEC Filings
      • SEDAR Filings
      • Financial Reports
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Leadership Team
      • Committee Composition
    • Investor Resources
      • Contact IR
      • FAQs
  • Corporate Responsibility

  • Corporate Responsibility
  • Careers

  • Careers
  • Contact Us

  • Contact Us
  • en
    • en
    • fr
  • btn Alerts

  • Sign up for Email Alerts

Social icons

Bio Details

Dawn Svoronos

Chair of the Board

Dawn Svoronos

Ms. Dawn Svoronos was elected to the Board of Directors and nominated as Chair of the Board of Theratechnologies in 2013.

Ms. Dawn Svoronos spent 23 years at Merck & Co. Inc. Prior to her retirement in 2011, she was President of the Europe/Canada region from 2009 to 2011 and President for Canada from 2006 to 2009. Previously, she held the positions of Vice President of Asia Pacific and Vice President of Global Marketing for the Arthritis, Analgesics and Osteoporosis franchise.

Ms. Svoronos sits on the Boards of Directors of PTC Therapeutics, Global Blood Therapeutics, Adverum Biotechnologies and Xenon Pharmaceuticals Inc. She also sat on the board of Endocyte and Medivation prior to their respective acquisitions.

Ms. Svoronos received a B.A. in English and French Literature from Carleton University.

  • Member of the Compensation Committee
  • Member of the Nominating and Corporate Governance Committee

Headquarters

Theratechnologies inc.
2015 Peel Street, 11th Floor
Montréal, Québec
Canada H3A 1T8
Phone: 514 336-7800
Fax: 514 331-9691

European Headquarters

Theratechnologies Europe Limited
2 Hume Street, 4th floor
Dublin 2
Ireland D02 DV24
Phone: +353 1 215 0650
europe@theratech.com

Investor Relations

Elif McDonald
Senior Director, Investor Relations
Phone: +1-438-315-8563
ir@theratech.com

US Headquarters

Theratechnologies U.S., Inc.
101 Hudson Street
21st Floor
Jersey City, New Jersey 07302

Main Nav

  • Home
  • About
  • Medicines & Pipeline
  • Investors
  • Corporate Responsibility
  • Careers
  • Contact Us
©2023 - Theratechnologies Inc.

Legal Nav

  • Terms of Use
  • Privacy

Search

Theratechnologies